Back to search results

Understanding Experiences of CLL Patients in Clinical Studies

This study aims to understand the experiences of people with chronic lymphocytic leukemia (CLL) who participate in other clinical trials. Researchers want to learn about the challenges different groups of patients face and why some patients complete a study while others withdraw. By looking at these experiences, especially across different demographic groups, the study hopes to find ways to improve future clinical trials for CLL patients. You can join if you are at least 18 years old, have CLL, and can understand the study information. The study plans to include 500 participants.

Study design
This is an observational study, meaning researchers will watch and collect information without giving any specific treatments. It aims to enroll 500 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will track how many patients complete a clinical study for up to 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05899543

Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients

UNKNOWN
Not specifiedAges 18+Observational
Power Life Sciences Inc.
~500 participants
Updated 2023-06-12 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of chronic lymphocytic leukemia patients who decide to join in a clinical study
Measured over 3 months
+1 more outcome measured

Conditions

Chronic Lymphocytic Leukemia

Explore related trials

Chronic Lymphocytic Leukemia

NCT05899543

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Power Life Sciences

    San Francisco, Californiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.

Who to contact

Michael B Gill
[email protected]
4159004227
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patient has been diagnosed with chronic lymphocytic leukemia
Patient is a minimum of 18 years or older
Able to comprehend the investigational nature of the protocol and provide informed consent

Exclusion

Pregnant or lactating women
Patients who are currently receiving any other investigational drug
Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial

What this trial measures

  • Number of chronic lymphocytic leukemia patients who decide to join in a clinical study3 months
  • Rate of patients who remain in an chronic lymphocytic leukemia clinical study to completion12 months